[1]
Mishra, V.V.; Gaddagi, R.A.; Aggarwal, R.; Choudhary, S.; Sharma, U.; Patel, U. Prevalence; characteristics and management of endometriosis amongst infertile women: A one year retrospective study. J. Clin. Diagn. Res., 2015, 9, QC01-QC03.
[2]
Menakaya, U.; Infante, F.; Condous, G. Consensus on current management of endometriosis. Hum. Reprod., 2013, 28(11), 3162-3163.
[3]
Ozawa, Y.; Murakami, T.; Terada, Y.; Yaegashi, N.; Okamura, K.; Kuriyama, S.; Tsuji, I. Management of the pain associated with endometriosis: An update of the painful problems. Tohoku J. Exp. Med., 2006, 210(3), 175-188.
[4]
Ferrero, S.; Remorgida, V.; Maganza, C.; Venturini, P.L.; Salvatore, S.; Papaleo, E.; Candiani, M.; Leone, R.; Maggiore, U. Aromatase and endometriosis: Estrogens play a role. Ann. N. Y. Acad. Sci., 2014, 1317, 17-23.
[5]
Taylor, R.N.; Kane, M.A.; Sidell, N. Pathogenesis of endometriosis: Roles of retinoids and inflammatory pathways. Semin. Reprod. Med., 2015, 33, 246-256.
[6]
Benagiano, G.; Brosens, I.; Lippi, D. The history of endometriosis. Gynecol. Obstet. Invest., 2014, 78, 1-9.
[7]
Burney, R.O.; Giudice, L.C. Pathogenesis and pathophysiology of endometriosis. Fertil. Steril., 2012, 98, 511-519.
[8]
Vlahos, N.F.; Economopoulos, K.P.; Fotiou, S. Endometriosis, in vitro fertilisation and the risk of gynaecological malignancies, including ovarian and breast cancer. Best Pract. Res. Clin. Obstet. Gynaecol., 2010, 24(1), 39-50.
[9]
Fan, Q.; Cai, Q.; Xu, Y. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. Oncotarget, 2015, 6(29), 27688-27699.
[10]
Yu, M.; Tang, Z.; Meng, F.; Tai, M.; Zhang, J.; Wang, R.; Liu, C.; Wu, Q. Elevated expression of FoxM1 promotes the tumor cell proliferation in hepatocellular carcinoma. Tumour Biol., 2016, 37(1), 1289-1297.
[11]
Nakamura, S.; Hirano, I.; Okinaka, K.; Takemura, T.; Yokota, D.; Ono, T.; Shigeno, K.; Shibata, K.; Fujisawa, S.; Ohnishi, K. The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia. Carcinogenesis, 2010, 31(11), 2012-2021.
[12]
Huang, C.; Du, J.; Xie, K. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis. Biochim. Biophys. Acta, 2014, 1845(2), 104-116.
[13]
Ma, R.Y.; Tong, T.H.; Leung, W.Y.; Yao, K.M. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1. Methods Mol. Biol., 2010, 647, 113-123.
[14]
Jin, H.; Park, M.H.; Kim, S.M. 3,3′-Diindolylmethane potentiates paclitaxel-induced antitumor effects on gastric cancer cells through the Akt/FOXM1 signaling cascade. Oncol. Rep., 2015, 33(4), 2031-2036.
[15]
Xie, Y.; Li, Y.; Kong, Y. OPN induces FoxM1 expression and localization through ERK 1/2, AKT, and p38 signaling pathway in HEC-1A cells. Int. J. Mol. Sci., 2014, 15(12), 23345-23358.
[16]
Gartel, A.L. Thiazole antibiotics siomycin and thiostrepton inhibit the transcriptional activity of FOXM1. Front. Oncol., 2013, 3, 150.
[17]
Vernon, M.W.; Wilson, E.A. Studies on the surgical induction of endometriosis in the rat. Fertil. Steril., 1985, 44(5), 684-694.
[18]
Zhang, H.; Zhao, X.; Liu, S.; Li, J.; Wen, Z.; Li, M. 17betaE2 promotes cell proliferation in endometriosis by decreasing PTEN via NFkappaB-dependent pathway. Mol. Cell. Endocrinol., 2010, 317(1-2), 31-43.
[19]
Gori, I.; Pellegrini, C.; Staedler, D.; Russell, R.; Jan, C.; Canny, G.O. Tumor necrosis factor-alpha activates estrogen signaling pathways in endometrial epithelial cells via estrogen receptor alpha. Mol. Cell. Endocrinol., 2011, 345(1-2), 27-37.
[20]
Ngô, C.; Nicco, C.; Leconte, M.; Chéreau, C.; Arkwright, S.; Vacher-Lavenu, M.C.; Weill, B.; Chapron, C.; Batteux, F. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo. J. Pathol., 2010, 222(2), 148-157.
[21]
Leconte, M.; Nicco, C.; Ngô, C.; Arkwright, S.; Chéreau, C.; Guibourdenche, J.; Weill, B.; Chapron, C.; Dousset, B.; Batteux, F. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am. J. Pathol., 2010, 177(6), 2963-2970.
[22]
Pearce, C.L.; Templeman, C.; Rossing, M.A.; Lee, A.; Near, A.M.; Webb, P.M.; Nagle, C.M.; Doherty, J.A.; Cushing-Haugen, K.L.; Wicklund, K.G.; Chang-Claude, J.; Hein, R.; Lurie, G.; Wilkens, L.R.; Carney, M.E.; Goodman, M.T.; Moysich, K.; Kjaer, S.K.; Hogdall, E.; Jensen, A.; Goode, E.L.; Fridley, B.L.; Larson, M.C.; Schildkraut, J.M.; Palmieri, R.T.; Cramer, D.W.; Terry, K.L.; Vitonis, A.F.; Titus, L.J.; Ziogas, A.; Brewster, W.; Anton-Culver, H.; Gentry-Maharaj, A.; Ramus, S.J.; Anderson, A.R.; Brueggmann, D.; Fasching, P.A.; Gayther, S.A.; Huntsman, D.G.; Menon, U.; Ness, R.B.; Pike, M.C.; Risch, H.; Wu, A.H.; Berchuck, A. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol., 2012, 13(4), 385-394.
[23]
Rossing, M.A.; Cushing-Haugen, K.L.; Wicklund, K.G.; Doherty, J.A.; Weiss, N.S. Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery. Cancer Causes Control, 2008, 19(10), 1357-1364.
[24]
Xue, J.; Lin, X.; Chiu, W.T.; Chen, Y.H.; Yu, G.; Liu, M.
Feng, X.H.; Sawaya, R.; Medema, R.H.; Hung, M.C.; Huang, S. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-beta-dependent cancer metastasis. J. Clin. Invest., 2014, 124(2), 564-579.
[25]
Cheng, S.L.; Wang, H.C.; Yu, C.J.; Tsao, P.N.; Carmeliet, P.; Cheng, S.J.; Yang, P.C. Prevention of elastase-induced emphysema in placenta growth factor knock-out mice. Respir. Res., 2009, 10, 115.
[26]
Jiang, L.; Wu, X.; Wang, P.; Wen, T.; Yu, C.; Wei, L.; Chen, H. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. J. Cancer Res. Clin. Oncol., 2015, 141, 971-981.
[27]
Ahmed, M.; Uddin, S.; Hussain, A.R.; Alyan, A.; Jehan, Z.; Al-Dayel, F.; Al-Nuaim, A.; Al-Sobhi, S.; Amin, T.; Bavi, P.; Al-Kuraya, K.S. FoxM1 and its association with matrix Metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab., 2012, 97(1), E1-E13.
[28]
Nicolaou, K.C.; Zak, M.; Rahimipour, S.; Estrada, A.A.; Lee, S.H.; O’Brate, A.; Giannakakou, P.; Ghadiri, M.R. Discovery of a biologically active thiostrepton fragment. J. Am. Chem. Soc., 2005, 127(43), 15042-15044.
[29]
Wang, X. The expanding role of mitochondria in apoptosis. Genes Dev., 2001, 15(22), 2922-2933.
[30]
Nishida, M.; Nasu, K.; Ueda, T.; Fukuda, J.; Takai, N.; Miyakawa, I. Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: A possible mechanism involved in the pathogenesis of endometriosis. Mol. Hum. Reprod., 2005, 11(1), 29-34.
[31]
Amaral, J.D.; Solá, S.; Steer, C.J.; Rodrigues, C.M. Role of nuclear steroid receptors in apoptosis. Curr. Med. Chem., 2009, 16(29), 3886-3902.
